Latest Dividend Declaration News

Alkane Resources Ltd has reported a remarkable half-year surge in revenue and profit, driven by its strategic merger with Mandalay Resources Corporation and soaring gold prices.

Dusk Group Limited reported a solid first half of FY26 with total sales rising 5.1% to $91.8 million, underpinned by product innovation and a successful AfterGlow store format trial. The company also announced a fully franked interim dividend of 4.0 cents per share.

Nick Scali Limited reported a robust 29% rise in net profit after tax for the first half of FY26, driven by strong growth in its ANZ operations despite ongoing UK store refurbishments and rebranding efforts.

Nick Scali Limited has reported a robust half-year performance with a 36% rise in net profit, driven by strong sales growth and margin improvements in Australia and New Zealand, while UK operations show signs of recovery following extensive store refurbishments.

Nick Scali Limited posted a robust half-year result with revenue up 7.2% and net profit soaring 36.4%, driven by strong ANZ growth despite ongoing UK losses. The company also declared a fully franked interim dividend of 39 cents per share.

Coast Entertainment Holdings Limited reported a robust 30.2% increase in revenue to $62.165 million for the half year ended December 2025, alongside a modest 1.4% rise in net profit. The company also completed a significant 10% on-market share buy-back.

Civmec Limited reports a 24.3% drop in revenue and a 19% fall in net profit for the half year ended December 2025, while advancing its naval shipbuilding footprint through the acquisition of Luerssen Australia.

GQG Partners delivered solid full-year 2025 results, with funds under management climbing 7.1% to US$163.9 billion and net income increasing 7.3% to US$463.3 million, despite net outflows. The firm maintained a strong dividend payout, reflecting confidence in its sustainable growth strategy.

GQG Partners Inc. reported a 6.3% increase in net revenue and a 7.3% rise in net profit for 2025, alongside a strategic US ETF launch and a new dividend declaration.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.

WT Financial Group has delivered a robust half-year performance with underlying net revenue up 19.3% and net profit after tax rising 14.4%, driven by adviser productivity and strategic investments.

AMP Limited's FY25 Data Pack highlights steady earnings with an underlying NPAT of $285 million, supported by strong Platforms net cashflows and a stable capital position. The report offers a detailed breakdown of business unit performance, costs, and market share.